Arbovirus laboratory capacity

Testing capacity by virus and assay type (ref Q17)

Regional office		CHIKVa						DENVa
		Ab	Mb	Gb	Nb	Pb		Ab	Mb	Gb	Nb	Pb
AMRO		0 (0%)	34 (65%)	0 (0%)	0 (0%)	34 (65%)		52 (100%)	52 (100%)	0 (0%)	15 (29%)	34 (65%)
EMRO		5 (25%)	10 (50%)	8 (40%)	2 (10%)	15 (75%)		9 (45%)	16 (80%)	14 (70%)	2 (10%)	16 (80%)
EURO		2 (11%)	16 (84%)	16 (84%)	9 (47%)	17 (89%)		11 (58%)	17 (89%)	16 (84%)	8 (42%)	18 (95%)
SEARO		5 (50%)	7 (70%)	7 (70%)	2 (20%)	8 (80%)		10 (100%)	10 (100%)	10 (100%)	5 (50%)	10 (100%)
WPRO		4 (25%)	10 (62%)	8 (50%)	6 (38%)	11 (69%)		14 (88%)	14 (88%)	13 (81%)	7 (44%)	12 (75%)
aOnly countries that responded to Q17 are included in the denominator when calculating these percentages
bA = Antigen testing; M = IgM antibody testing; G = IgG antibody testing; N = Neutralizing antibody testing; P = RT-PCR or other nucleic acid amplification test

Regional office		YFVa						ZIKVa
		Ab	Mb	Gb	Nb	Pb		Ab	Mb	Gb	Nb	Pb
AMRO		0 (0%)	21 (40%)	0 (0%)	0 (0%)	29 (56%)		0 (0%)	34 (65%)	0 (0%)	0 (0%)	33 (63%)
EMRO		4 (20%)	6 (30%)	5 (25%)	2 (10%)	11 (55%)		3 (15%)	6 (30%)	6 (30%)	2 (10%)	11 (55%)
EURO		3 (16%)	15 (79%)	15 (79%)	8 (42%)	16 (84%)		3 (16%)	17 (89%)	16 (84%)	7 (37%)	17 (89%)
SEARO		0 (0%)	0 (0%)	0 (0%)	0 (0%)	1 (10%)		1 (10%)	1 (10%)	1 (10%)	1 (10%)	7 (70%)
WPRO		2 (12%)	3 (19%)	2 (12%)	4 (25%)	8 (50%)		5 (31%)	7 (44%)	6 (38%)	8 (50%)	12 (75%)
aOnly countries that responded to Q17 are included in the denominator when calculating these percentages.
bA = Antigen testing; M = IgM antibody testing; G = IgG antibody testing; N = Neutralizing antibody testing; P = RT-PCR or other nucleic acid amplification test